Source: International Congress 2016 – New genomic targets in pulmonary disease
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Stephen Murphy (Rochester, United States of America), Stephen Murphy, Faye Harris, Giannoula Karagouga, Dennis Wigle, George Vasmatzis, Marie Christine Aubry. Determining genomic rearrangements in clinical lung specimens for assessment of metastatic disease, actionable targets and disease monitoring. Eur Respir J 2016; 48: Suppl. 60, 1781

Member's Comments

No comment yet.

Related content which might interest you: Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP) Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy Year: 2013 Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Exploiting metabolomic approaches to aid in the diagnosis of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Optimization of cfDNA routine use for NSCLC genomic alteration analysis Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 The diagnostic puzzle of ALK rearrangement in lung cancer. A novel intron related abnormality Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 The art of detecting EML4-ALK gene rearrangements in NSCLC patients – Immediate implications for patient care Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 MET genetic lesions in NSCLC are functional markers of early hematogenous spreading and radioresistance Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Prevalence of molecular changes in resected pulmonary adenocarcinomas Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Large-scale quantitative proteomic analysis identifies pathways in COPD-associated lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Telomere-associated gene network in lung adenocarcinoma Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 The impact of pulmonary rehabilitation on preoperative inflammatory markers in lung cancer patients Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Development and validation of a prognostic index for survival in patients with non-small-cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 High-throughput detection of alternative splicing in patients with non-small cell lung cancer treated by bevacizumab/erlotinib Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer Year: 2014 Novel survey tool used to assess priorities of lung cancer patients and carers Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Metabolic modification as a potential therapeutics approach in lung cancer Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Development of an invasive 3D lung tumor model for oncological research Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013